SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367920-20-000044
Filing Date
2020-10-30
Accepted
2020-10-30 07:58:02
Documents
14
Period of Report
2020-10-28
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K cnce-20201028.htm   iXBRL 8-K 34295
  Complete submission text file 0001367920-20-000044.txt   178966

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnce-20201028.xsd EX-101.SCH 2438
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cnce-20201028_cal.xml EX-101.CAL 720
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnce-20201028_def.xml EX-101.DEF 1653
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnce-20201028_lab.xml EX-101.LAB 24935
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnce-20201028_pre.xml EX-101.PRE 13200
7 EXTRACTED XBRL INSTANCE DOCUMENT cnce-20201028_htm.xml XML 11519
Mailing Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421
Business Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36310 | Film No.: 201274774
SIC: 2834 Pharmaceutical Preparations